Approval · Notice of Compliance 26265 · 2021
DIACOMIT: Notice of Compliance 26265
Issued July 15, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26265
- Date
- July 15, 2021
- Company
- Biocodex SasGentilly, Cedex, France
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To convert the Product Monograph to the most recent master template (2020) and update the package labels as per the Plain Language Labelling requirements.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIACOMIT | Not yet assigned | — |
Medicinal ingredients
- STIRIPENTOL 250 MG per CAP
- STIRIPENTOL 500 MG per CAP
- STIRIPENTOL 250 MG per SACHET
- STIRIPENTOL 500 MG per SACHET